🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the makers of acetaminophen, claiming the firms hid safety concerns that the pain reliever created to pediatric neurological development.

This legal action comes a month after Donald Trump publicized an unproven link between using Tylenol - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in offspring.

The attorney general is filing suit against J&J, which previously sold the medication, the exclusive pain medication approved for pregnant women, and Kenvue, which now manufacturers it.

In a official comment, he stated they "betrayed America by making money from pain and marketing drugs regardless of the potential hazards."

Kenvue states there is insufficient reliable data linking Tylenol to autism spectrum disorder.

"These companies misled for generations, deliberately risking millions to boost earnings," the attorney general, a Republican, declared.

Kenvue commented that it was "deeply concerned by the spread of false claims on the reliability of paracetamol and the likely effects that could have on the welfare of US mothers and children."

On its official site, the company also mentioned it had "consistently assessed the applicable studies and there is insufficient valid information that demonstrates a proven link between taking acetaminophen and autism."

Associations representing physicians and health professionals share this view.

The American College of Obstetricians and Gynecologists has said paracetamol - the key substance in acetaminophen - is a restricted selection for expectant mothers to address discomfort and elevated temperature, which can present serious health risks if left untreated.

"In over twenty years of research on the use of acetaminophen in gestation, not a single reputable study has definitively established that the use of paracetamol in any stage of gestation leads to brain development issues in young ones," the organization said.

This legal action references current declarations from the former administration in asserting the medication is potentially dangerous.

Last month, the former president generated worry from health experts when he advised pregnant women to "resist strongly" not to use Tylenol when ill.

The FDA then issued a notice that physicians should consider limiting the use of acetaminophen, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in minors has remains unverified.

The Health Department head Robert F Kennedy Jr, who manages the Food and Drug Administration, had promised in spring to undertake "comprehensive study program" that would establish the origin of autism spectrum disorder in a limited time.

But experts cautioned that finding a sole reason of autism - believed by scientists to be the consequence of a intricate combination of inherited and external influences - would be difficult.

Autism is a category of permanent neurological difference and condition that impacts how individuals perceive and relate to the surroundings, and is recognized using doctors' observations.

In his court filing, the attorney general - a Trump ally who is seeking the Senate - alleges the manufacturer and J&J "intentionally overlooked and attempted to silence the science" around paracetamol and autism spectrum disorder.

The lawsuit attempts to require the companies "remove any commercial messaging" that asserts acetaminophen is reliable for women during pregnancy.

This legal action echoes the complaints of a group of parents of minors with autism and ADHD who sued the producers of Tylenol in two years ago.

Judicial authorities threw out the legal action, declaring investigations from the plaintiffs' authorities was not conclusive.